Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CAMPBELL'S CoCPB · Entity 3700 | Vice President | December 09, 2016 | December 12, 2016 |
| Trevi Therapeutics, Inc.TRVI · Entity 4387 | 10% owner | May 07, 2019 | May 07, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CAMPBELL'S Co
Report date December 09, 2016 · Filed December 12, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectRevocable Trust | 5,000 |
Reported balance
After 2016-12-09 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2016-12-09 · Gift · Disposed 4,000 · Balance 5,000 |
| Common StockSEC Table I · non-derivative | Direct | 24,465 |
Reported balance
Holding disclosure · report date 2016-12-09 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 24,465 |
| Common StockSEC Table I · non-derivative | Indirect401(k) | 763.09 |
Reported balance
Holding disclosure · report date 2016-12-09 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 763.09 F1: Represents routine transactions under the issuer's 401(k) Plan since the date of the reporting person's last report. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents routine transactions under the issuer's 401(k) Plan since the date of the reporting person's last report.
Trevi Therapeutics, Inc.
Report date May 07, 2019 · Filed May 07, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,034 |
Reported balance
Holding disclosure · report date 2019-05-07 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 15,034 |
| Series A Preferred StockSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2019-05-07 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance Not disclosed F1: The Series A Preferred Stock and the dividends that have accrued thereon to date are convertible on a 9.5-for-one basis into the number of shares of Common Stock shown in Column 3 without payment of further consideration at the holder's election or automatically upon the closing of the Issuer's initial public offering. The number of shares of Common Stock into which the Series A Preferred Stock and accrued dividends thereon are convertible will increase on a daily basis without payment of further consideration as additional dividends accrue. The shares have no expiration date. |
| Series C Preferred StockSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2019-05-07 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance Not disclosed F2: The Series C Preferred Stock and the dividends that have accrued thereon to date are convertible on a 9.5-for-one basis into the number of shares of Common Stock shown in Column 3 without payment of further consideration at the holder's election or automatically upon the closing of the Issuer's initial public offering. The number of shares of Common Stock into which the Series C Preferred Stock and accrued dividends thereon are convertible will increase on a daily basis without payment of further consideration as additional dividends accrue. The shares have no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: The Series A Preferred Stock and the dividends that have accrued thereon to date are convertible on a 9.5-for-one basis into the number of shares of Common Stock shown in Column 3 without payment of further consideration at the holder's election or automatically upon the closing of the Issuer's initial public offering. The number of shares of Common Stock into which the Series A Preferred Stock and accrued dividends thereon are convertible will increase on a daily basis without payment of further consideration as additional dividends accrue. The shares have no expiration date.
F2: The Series C Preferred Stock and the dividends that have accrued thereon to date are convertible on a 9.5-for-one basis into the number of shares of Common Stock shown in Column 3 without payment of further consideration at the holder's election or automatically upon the closing of the Issuer's initial public offering. The number of shares of Common Stock into which the Series C Preferred Stock and accrued dividends thereon are convertible will increase on a daily basis without payment of further consideration as additional dividends accrue. The shares have no expiration date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 09, 2016 Filed Dec 12, 2016 20:45 UTC | CAMPBELL'S Co CPB · Entity 3700 | GiftCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000016732-16-000174 · wf-form4_148157550381555.xml · nonDerivative · entry 1 O'Shea William J · CIK 0001607050 · Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 5,000 Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 18:33 UTC | CAMPBELL'S Co CPB · Entity 3700 | Tax withholdingCommon Stock | 1,859 | $54.38 | $101,092.42 |
DisclosureSEC source: 0000016732-16-000153 · wf-form4_147560596861566.xml · nonDerivative · entry 2 O'Shea William J · CIK 0001607050 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,465 Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 18:33 UTC | CAMPBELL'S Co CPB · Entity 3700 | Disposition to issuerCommon Stock | 2,628 | $0.00 | $0.00 |
DisclosureSEC source: 0000016732-16-000153 · wf-form4_147560596861566.xml · nonDerivative · entry 1 O'Shea William J · CIK 0001607050 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,324 F1 · shares: Represents number of shares previously reported as acquired by the reporting person that were forfeited because the performance criteria required for vesting were not met. Read SEC document |
| September 02, 2016 Filed Sep 6, 2016 15:43 UTC | CAMPBELL'S Co CPB · Entity 3700 | SaleCommon Stock | 13,000 | $57.74 | $750,620.00 |
DisclosureSEC source: 0000016732-16-000137 · wf-form4_147317658059573.xml · nonDerivative · entry 1 O'Shea William J · CIK 0001607050 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,952 F1 · price: The price reflects the weighted average sale price for the transactions reported on this line. The range of prices for the transactions reported on this line were $57.635 to and including $57.78. The reporting person undertakes to provide the issuer, any security holder of the issuer or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.